Key Market Indicators
Sales of antidepressant medication in Iceland are projected to climb to approximately $12 million by 2028, up from around $11 million in 2023. This reflects an annual compound growth rate of 1.9%. Since 1994, the Icelandic market for these medications has seen an average annual increase of 6.3%. In the latest rankings for 2023, Iceland placed 15th, with Slovenia narrowly overtaking it with similar sales figures. Leading the global market are Spain, Italy, and Australia, which hold the second, third, and fourth positions, respectively.
